Form 4 for ATEX Anterix Inc.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0001304492-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-12 | 2024-03-08 | ATEX | Schwartz Robert Harris | Pres, CEO, Dir | A - Grant | $0.00 | +21.5K | 114.5K | +23% | $0 |
| D | 2024-03-12 | 2024-03-08 | ATEX | Schwartz Robert Harris | Pres, CEO, Dir | A - Grant | $0.00 | +127.2K | 127.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | A | A | 21,528 | $0.00 | 114,467 | D | — | — | (F1) Represents the issuance of restricted stock units (the "RSUs"). 1/3 of the RSUs vest on May 22, 2025, with the remaining RSUs vesting in 2 equal annual installments thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-03-08 | A | A | 127,189 | $0.00 | 127,189 | D | $36.00 · 2025-05-22 to 2034-03-09 | 127,189 Common Stock | (F2) 1/3 of the option shares vest and become exercisable on May 22, 2025, with the remaining option shares vesting in 2 equal annual installments thereafter. |